Cite
HARVARD Citation
Zhai, Y. et al. (n.d.). Continuous intravenous infusion of recombinant human endostatin combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer (HELPER): a phase 2, multicentre study. Lancet oncology. pp. S11-. [Online].